Neuronal control of fascia
The NEUROFASCIA project aims to explore the fascia's role in brain-immune communication and its implications for pain and inflammation, using advanced techniques to characterize and modulate this tissue.
Projectdetails
Introduction
The fascia is the largest tissue in the body, yet most of us have never heard of it. This connective tissue delineates the skin, surrounds muscles, and closely envelops all organs. Clinically, it is mainly considered a mechanical barrier separating organs and muscles.
Importance of Fascia
But why should a simple barrier be populated with immune cells and receive extensive innervation by sensory and sympathetic neurons? Here we propose that the fascia generates a sensory platform that detects damage to the tissues it envelops and communicates this information to the brain, which in turn initiates corrective programs and modulates immune activity.
Preliminary Results
Our preliminary results support this hypothesis, indicating that chronic depression in mice and direct optogenetic activation of sympathetic fascia innervations induce immune changes in the fascia.
Research Aims
We propose three major aims:
- Characterization: Identify the anatomical and genetic characteristics of fascia innervation and fascia resident immune cells.
- Function: Determine how fascia inflammation is represented in the brain and how it affects pain responses.
- Modulation: Demonstrate how neural control of the fascia affects this tissue and its immune state.
Methodology
My multidisciplinary background uniquely positions me to study this novel aspect of brain-body communication. We will use:
- Viral tracing and spatial transcriptomics to characterize the fascia’s innervation.
- Optogenetics to locally control neurons in the fascia.
- Chemogenetics to manipulate brain activity.
- High-dimensional immune characterization to establish the immunological outcomes in the fascia.
Potential Impact
NEUROFASCIA has the potential to transform our understanding of brain-immune communication and open new therapeutic avenues for diseases such as myofascial pain syndrome, endometriosis, and fibromyalgia, which are accompanied by low-grade inflammation and altered fascia innervation.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.000.000 |
Totale projectbegroting | € 2.000.000 |
Tijdlijn
Startdatum | 1-7-2023 |
Einddatum | 30-6-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGYpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Architecture of Peripheral Neuroimmune Circuits and SynapsesThis project aims to explore neuro-ILC2 interactions in vivo using innovative labelling tools to enhance understanding of neuroimmune dynamics and their implications for tissue health and disease. | ERC Advanced... | € 3.500.000 | 2024 | Details |
Control of body weight by specialized brain-adipose loop neuronsThis project aims to identify and manipulate brain circuits involved in non-hormonal communication with white adipose tissue to enhance understanding and treatment of obesity. | ERC Starting... | € 1.499.521 | 2024 | Details |
Network Synergies in Tissue Homeostasis and Stromal Prevention of Inflammatory Disease.This project aims to uncover the mechanisms of tissue homeostasis and stromal biology to prevent inflammation onset, using advanced bioimaging and computational techniques for therapeutic advancements. | ERC Starting... | € 1.499.514 | 2022 | Details |
Spatio-temporal integration of skin inflammationThe project aims to elucidate spatio-temporal inflammasome signaling in keratinocytes to identify new therapeutic targets for inflammatory skin disorders like atopic dermatitis and psoriasis. | ERC Advanced... | € 2.499.188 | 2023 | Details |
Illuminating body-brain communication channels at the choroid plexus and their impact on brain physiology.The BrainGate project aims to elucidate the gut-blood-choroid plexus-brain communication axis's role in brain function and development using innovative genetic and transcriptomic techniques. | ERC Starting... | € 1.499.514 | 2023 | Details |
Architecture of Peripheral Neuroimmune Circuits and Synapses
This project aims to explore neuro-ILC2 interactions in vivo using innovative labelling tools to enhance understanding of neuroimmune dynamics and their implications for tissue health and disease.
Control of body weight by specialized brain-adipose loop neurons
This project aims to identify and manipulate brain circuits involved in non-hormonal communication with white adipose tissue to enhance understanding and treatment of obesity.
Network Synergies in Tissue Homeostasis and Stromal Prevention of Inflammatory Disease.
This project aims to uncover the mechanisms of tissue homeostasis and stromal biology to prevent inflammation onset, using advanced bioimaging and computational techniques for therapeutic advancements.
Spatio-temporal integration of skin inflammation
The project aims to elucidate spatio-temporal inflammasome signaling in keratinocytes to identify new therapeutic targets for inflammatory skin disorders like atopic dermatitis and psoriasis.
Illuminating body-brain communication channels at the choroid plexus and their impact on brain physiology.
The BrainGate project aims to elucidate the gut-blood-choroid plexus-brain communication axis's role in brain function and development using innovative genetic and transcriptomic techniques.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A synaptic mechanogenetic technology to repair brain connectivityDeveloping a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy. | EIC Pathfinder | € 3.543.967 | 2023 | Details |
A synaptic mechanogenetic technology to repair brain connectivity
Developing a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy.